GLP-3 (Ret) Cognitive Effects Research 2026
Retatrutide cognitive effects research in 2026: new learning and memory study, mechanism context, comparisons, and research-only FAQ.
MOTS-c Weekly Research Brief
MOTS-c research trends, BPC-157 product highlight, and a study-design tip for peptide research interpretation.
MOTS-c Research Update: June 2026 Studies
MOTS-c research update for 2026: cardiac inflammation, metabolic signaling, evidence limits, and research-only FAQ.
Oral GLP-1 Research Notes
A concise Webber Science brief on oral GLP-1 research, peptide education resources, and careful research reading for Canadian women 40+.
GLP-3 (Ret) Research Update: GLP-1 Trends
Subject: GLP-3 (Ret) Research Update: GLP-1 Trends GLP-3 (Ret) continues to stand out as one of the most closely watched metabolic research compounds in the current peptide landscape. In recent trend monitoring, GLP-3 (Ret) showed strong year-over-year search growth and…
Are Peptides Legal Again? FDA Peptide Reclassification, BPC-157 Status & What Changed in 2026
On April 15, 2026, the FDA made one of the most significant regulatory moves in the peptide space in years: they removed 12 peptides — including BPC-157, TB-500, and Semax — from the Category 2 restricted substances list. If you’ve…
BPC-157 Side Effects: What the Research Says (FAQ)
A comprehensive research-based FAQ on BPC-157 side effects, covering what preclinical data shows, common questions from the research community, and important safety context.
BPC-157: Complete Guide for Canadian Researchers
Everything Canadian researchers need to know about BPC-157 (Body Protection Compound 157): mechanism of action, wellness applications, reconstitution, storage, safety considerations, and regulatory status in Canada.
Peptide 101: New to Peptides? Start Here
New to peptides? Start here. A comprehensive guide covering what peptides are, how they work, what the research says, and how to evaluate suppliers. Written for Canadians.
CJC-1295: Complete Guide for Canadian Researchers
Complete guide for Canadian researchers on CJC-1295 peptides, covering DAC vs no-DAC differences, wellness applications, dosing protocols, storage guidelines, and Canadian regulatory considerations.